ABN Newswire is a business newswire and press release distribution service for listed companies on stock exchanges globally. ABN Newswire distributes company announcements to the professional platforms, finance portals and syndicates important corporate news to a wide variety of news aggregators and financial news systems.
Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
Analytik Jena AG (Prime Standard; DE0005213508) received at the beginning of the new fiscal year the acceptance of a contract for several CDC (Center for Disease Control and prevention) projects in China. In six provinces in China, Analytik Jena will provide analytical instruments. Overall, the German based producer of highly innovative equipment will deliver 90 instruments. The scope of supply includes Atomic-Absorption-Spectrometer 41 ZEEnit, 43 UVVIS Spectrofotometer Specord and 6 Sum Parameters Instruments multi N/C. The order volume amounts to more than 2.5 Mio Euro. The instruments are used to equip CDC centres in Sichuan, Yunnan, Guizhou, Inner Mongolia, Shaanxi, and Gansu.
The CEO of Analytik Jena, Klaus Berka, comments as follows: "These contracts are further steps to strengthen our presence in the Asian market. Specifically in the emerging markets the products of Analytik Jena prove to be highly competitive and our distribution network is very efficient."
The products come from analytical solutions, the strongest business unit of Analytik Jena. The unit produces classical analytical systems based on optical spectroscopy and elemental analysis. Torsten Olschewski, vice president Sales, Service and Marketing outlines the importance of China in the future development: "China has already become our biggest foreign sales market. To gain further market share in China is a strategic mission for Analytik Jena in the near future. Signing the deal is an important step forward."
Contact: Dr. Mario Voigt Analytik Jena AG Corporate Communications and Investor Relations
Analytik Jena AG Konrad-Zuse-Straße 1 Jena Germany
WKN: 521350 ; ISIN: DE0005213508 ; Index: Prime All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;